Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
12/2010
12/07/2010CA2436409C Kappa opioid receptor ligands
12/07/2010CA2434203C 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
12/07/2010CA2381802C Synergistic combination of roflumilast and salmeterol
12/02/2010WO2010138794A2 Regulation of sodium channels by plunc proteins
12/02/2010WO2010137939A1 Method for producing a nutraceutical composition and the nutraceutical produced by the method
12/02/2010WO2010137620A1 Phenoxyethylamine derivative
12/02/2010WO2010137484A1 Anti-shock agent comprising diaminotrifluoromethylpyridine derivative
12/02/2010WO2010137160A1 Prophylactic or therapeutic agent for pulmonary fibrosis
12/02/2010WO2010137012A1 Peptide therapy for amphiregulin mediated diseases
12/02/2010WO2010136481A1 Il-13 binding protein
12/02/2010WO2010136153A1 A therapeutic combination comprising a pulmonary surfactant and a steroid
12/02/2010WO2010107957A3 RNA INTERFERENCE MEDIATED INHIBITION OF GATA BINDING PROTEIN 3 (GATA3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/02/2010WO2010103547A3 Substituted fused pyrimidine compounds
12/02/2010US20100305500 Hyaluronidase as an adjuvant for increasing the injection volume and dispersion of large diameter synthetic membrane vesicles containing a therapeutic agent
12/02/2010US20100305200 Compounds that modulate intracellular calcium
12/02/2010US20100305194 Modified and stabilized gdf propeptides and uses thereof
12/02/2010US20100305191 Rna interference mediated inhibition of adenosine a1 receptor (adora1) gene expression using short interfering rna
12/02/2010US20100305164 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases
12/02/2010US20100305159 Crystalline form of piperidine compound
12/02/2010US20100305156 Inhibitors of c-met protein kinase
12/02/2010US20100305147 Chemically modified small molecules
12/02/2010US20100305146 Method for the Production of 1,3-Dioxolane-2-Ones and Carboxylic Acid Esters by Means of Transacylation in Basic Reaction Conditions
12/02/2010US20100305143 Pyrrolopyrimidine compounds
12/02/2010US20100305106 Inhibitors of fatty acid uptake and methods of use
12/02/2010US20100305104 Oxadiazole Diaryl Compounds
12/02/2010US20100305094 Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha
12/02/2010US20100305092 Triazole oxadiazoles derivatives
12/02/2010US20100305080 Novel Crystalline Salts of Montelukast
12/02/2010US20100305071 Methods for improving healing of an oral lesion using a glycerophosphate salt
12/02/2010US20100305033 Hydroxyalkyl starch derivatives and process for their preparation
12/02/2010US20100305024 Methods of inhibiting calcineurin with apoe analogs
12/02/2010US20100303921 Pharmaceutical Compositions Comprising Cereal Beta (1-3) Beta (1-4) Glucan
12/02/2010US20100303918 Compositions and methods for treating asthma and other lung disorders
12/02/2010US20100303916 Enhanced drug delivery with orientable particles
12/02/2010US20100303908 Pharmaceutical composition comprising desloratadine
12/02/2010US20100303896 5beta, 14beta-androstane derivatives useful for the treatment of restenosis after angioplastic or endoartherectomy and diseases due to organ fibrosis
12/02/2010US20100303871 Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction
12/02/2010US20100303822 Polypeptides from non-typeable haemophilus influenzae
12/02/2010US20100303821 Immunoglobulins
12/02/2010US20100303820 Methods of treatment using il-17e antagonists
12/02/2010US20100303782 Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
12/02/2010US20100303758 Novel Glucocorticoid Receptor Agonists
12/02/2010US20100300433 Substrates for Enhancing Purity or Yield of Compounds Forming a Condensation Aerosol
12/02/2010CA2763941A1 Compositions, methods & systems for respiratory delivery of two or more active agents
12/02/2010CA2763939A1 Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting b2 adrenergic receptor agonists and associated methods and systems
12/02/2010CA2763936A1 Compositions for respiratory delivery of active agents and associated methods and systems
12/02/2010CA2763443A1 Il-13 binding protein
12/02/2010CA2763402A1 A therapeutic combination comprising a pulmonary surfactant and a steroid
12/02/2010CA2761597A1 Anti-shock agent comprising diaminotrifluoromethylpyridine derivative
12/01/2010EP2256199A1 Therapeutic uses of BR43X2 soluble receptors
12/01/2010EP2255811A1 Mequitazine for treating or preventing pathologies involving histamine H4 receptors
12/01/2010EP2255801A1 Pharmaceutically active isoindoline derivatives
12/01/2010EP2255668A2 Production and Use of a Polar Lipid-Rich Fraction Containing Omega-3 and/or Omega-6 Highly Unsaturated Fatty Acids from Microbes, Genetically Modified Plant Seeds and Marine Organisms
12/01/2010EP2255189A2 Compositions and methods which modulate g-protein signaling for the treatment of asthma
12/01/2010EP2254860A1 Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the b2 adrenergic receptor
12/01/2010EP2254581A1 Pteridine derivatives for treating respiratory disease
12/01/2010EP1951721B1 3 -monosubstituted tropane derivative as nociceptin receptor ligand
12/01/2010EP1806141B1 Par-2 antagonists
12/01/2010EP1414861B1 Humanized antibodies against icam-1, their production and uses
12/01/2010EP1244790B1 Nucleic acids encoding polypeptides having chips activity
12/01/2010CN1872045B Drop pills of lysionotin, and preparation method
12/01/2010CN1847261B Cyclic peptides as g-protein-coupled receptor antagonists
12/01/2010CN101903389A Pharmaceutically acceptable salts of methyl (3-{ [[3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl] (3- morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy
12/01/2010CN101903384A [1h-pyrazolo [3, 4-b] pyridine-4-yl]-phenyle or -pyridin-2-yle derivatives as protein kinase C-theta
12/01/2010CN101903362A Tetrazole-substituted arylamide derivatives and their use as P2X3 and/or P2X2/3 purinergic receptor antagonists
12/01/2010CN101903359A Triazole-substituted arylamide derivatives and their use as P2X3 and /or P2X2/3 purinergic receptor antagonists
12/01/2010CN101903356A 4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof
12/01/2010CN101903023A P-menthawe-3-carboxylic acid esters to treat airways diseases
12/01/2010CN101899416A Recombinant rat myeloma cell NS0-F10 and application thereof
12/01/2010CN101899078A Extraction method of glossy privet fruit glycoside and application of glossy privet fruit glycoside in preparation of medicament
12/01/2010CN101899058A Method for preparing thiazolopyrimidine compound and application thereof
12/01/2010CN101899053A C crystal form solid matter of bergenin and preparation method and application thereof
12/01/2010CN101899052A B-crystal form solid matter of bergenin and preparation method and application thereof
12/01/2010CN101897954A Composition, preparation method thereof and use thereof
12/01/2010CN101897938A Ginger tea beverage for treating cold and abating fever
12/01/2010CN101897917A Chinese medicinal preparation for treating whooping cough
12/01/2010CN101897905A Chinese medicament for treating bronchiectasis hemoptysis
12/01/2010CN101897903A Quality control method of chewable tablets for treating cold and clearing heat
12/01/2010CN101897901A Traditional Chinese medicine for treating mixed asthma
12/01/2010CN101897892A Method for preparing injection of traditional Chinese medicine glabrous sarcandra herb
12/01/2010CN101897889A Chinese medicinal composition for treating pediatric pneumonia and preparation method thereof
12/01/2010CN101897884A Formula of traditional Chinese medicine for treating cough and asthma caused by tracheitis
12/01/2010CN101897883A Traditional Chinese medicine for treating chronic bronchitis
12/01/2010CN101897870A Phlegm-eliminating calyx cucumis wine
12/01/2010CN101897847A Traditional Chinese medicine for curing asthma
12/01/2010CN101897831A Method for extracting and separating medlar total alkaloids from medlar
12/01/2010CN101897761A Chinese medicinal preparation for treating infantile pneumonia
12/01/2010CN101897760A Detection method of Santanning syrup
12/01/2010CN101897757A Chinese medicinal pills for treating influenza
12/01/2010CN101897756A Silver yellow medicinal preparation containing polyethylene glycol 12-hydroxy stearate and preparation method thereof
12/01/2010CN101897744A Medicament for eliminating phlegm and relieving asthma, preparation method thereof and use thereof
12/01/2010CN101897740A Glabrous sarcandra herb formula particle and preparation method thereof
12/01/2010CN101897728A Preparation method for traditional Chinese medicine earthworm injection
12/01/2010CN101897724A Method for producing a soft tissue filler and method for producing an adipose tissue transplant
12/01/2010CN101897720A Medicinal composition for treating respiratory disease
12/01/2010CN101897719A Medical composite used for treating smoke inhalation lung injury
12/01/2010CN101897715A Nuezhenoside and rhoifolin composition and use thereof in preparation of drugs
12/01/2010CN101897688A Medicinal preparation for treating phthisis
12/01/2010CN101897680A Liquid capsule preparation, preparation method and application thereof
12/01/2010CN101897671A Xylitol micro pill preparations and preparation method thereof
1 ... 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 ... 878